Reva Medical Inc (RVAAX) financial statements (2022 and earlier)
Company profile
| Business Address |
5751 COPLEY DRIVE SAN DIEGO, CA 92111 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments, including: | 20 | 7 | 17 | 27 | 21 | 44 | ||
| Cash and cash equivalents | 19 | 7 | 17 | 26 | 19 | 39 | ||
| Short-term investments | 1 | 1 | 1 | 5 | ||||
| Other undisclosed cash, cash equivalents, and short-term investments | (0) | |||||||
| Receivables | 0 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 1 | ✕ | ✕ | |||||
| Inventory | 1 | |||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Other undisclosed current assets | 0 | 0 | 0 | 0 | 0 | |||
| Total current assets: | 21 | 7 | 17 | 27 | 21 | 45 | ||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 1 | 2 | 3 | 3 | 4 | 3 | ||
| Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | ✕ | ||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Total noncurrent assets: | 2 | 2 | 3 | 3 | 4 | 3 | ||
| TOTAL ASSETS: | 23 | 9 | 20 | 30 | 25 | 47 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 2 | 7 | 3 | 4 | 3 | 2 | ||
| Accounts payable | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Accrued liabilities | 2 | 2 | 2 | 2 | 2 | 2 | ||
| Employee-related liabilities | 1 | |||||||
| Taxes payable | 0 | |||||||
| Interest and dividends payable | 4 | |||||||
| Debt | 92 | |||||||
| Deferred revenue and credits | 0 | 0 | 0 | 0 | ||||
| Other undisclosed current liabilities | (1) | (0) | (0) | |||||
| Total current liabilities: | 3 | 99 | 3 | 3 | 3 | 2 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 99 | 1 | ||||||
| Long-term debt, excluding current maturities | 99 | 1 | ||||||
| Liabilities, other than long-term debt | 1 | 0 | 3 | 0 | 1 | 1 | ||
| Deferred revenue and credits | 0 | 0 | 1 | 1 | ||||
| Other liabilities | 1 | 0 | 2 | |||||
| Other undisclosed noncurrent liabilities | 13 | 95 | 53 | (0) | (0) | |||
| Total noncurrent liabilities: | 113 | 0 | 97 | 54 | 0 | 1 | ||
| Total liabilities: | 115 | 99 | 101 | 57 | 4 | 3 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | (93) | (90) | (81) | (26) | 21 | 45 | ||
| Common stock | 0 | 0 | 0 | 0 | ||||
| Additional paid in capital | 289 | 300 | 255 | 226 | 222 | 218 | ||
| Accumulated other comprehensive loss | (0) | |||||||
| Accumulated deficit | (382) | (389) | (335) | (253) | (202) | (174) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | ||||||
| Total stockholders' equity: | (93) | (90) | (81) | (26) | 21 | 45 | ||
| TOTAL LIABILITIES AND EQUITY: | 23 | 9 | 20 | 30 | 25 | 47 | ||
Income statement (P&L) ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 0 | ||||||
| Cost of revenue | (0) | (0) | |||||
| Cost of goods and services sold | (0) | (0) | |||||
| Gross profit: | 0 | (0) | |||||
| Operating expenses | (21) | (27) | (24) | (22) | (28) | (24) | |
| Other undisclosed operating income | 0 | ||||||
| Operating loss: | (21) | (27) | (24) | (22) | (28) | (24) | |
| Nonoperating income (expense) | 28 | (27) | (59) | (29) | 0 | 0 | |
| Investment income, nonoperating | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other nonoperating income (expense) | (0) | (0) | 0 | 0 | (0) | (0) | |
| Interest and debt expense | (7) | (2) | (2) | (1) | |||
| Net income (loss): | 0 | (56) | (84) | (52) | (28) | (24) | |
| Other undisclosed net income attributable to parent | 7 | 2 | 2 | 1 | |||
| Net income (loss) available to common stockholders, basic: | 7 | (54) | (83) | (51) | (28) | (24) | |
| Interest on convertible debt | 2 | ||||||
| Other undisclosed net loss available to common stockholders, diluted | (31) | ||||||
| Net loss available to common stockholders, diluted: | (21) | (54) | (83) | (51) | (28) | (24) | |
Comprehensive Income ($ in millions)
| 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | 0 | (56) | (84) | (52) | (28) | (24) | |
| Comprehensive income (loss): | 0 | (56) | (84) | (52) | (28) | (24) | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 7 | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | 7 | (56) | (84) | (52) | (28) | (24) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.